Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AM... von Agrawal, Vaibhav, Croslin, Cindy, Beltran, Asuscena L., Zhang, Jianying, Palmer, Joycelynne, Huynh-Tran, Quy, Hernandez, Rochelle, Thomas, Sandra, Robbins, Marjorie, Aribi, Ahmed, Ali, Haris, Stein, Anthony S., Budde, Elizabeth L., Al Malki, Monzr M., Marcucci, Guido

Volltext

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL von Sandhu, Karamjeet S., Macias, Alan, Del Real, Marissa, Beltran, Asuscena L., Kim, Young Sun, Zhang, Jianying, Palmer, Joycelynne, Robbins, Marjorie, Loomis, Reyna, Akhtari, Mojtaba, Aribi, Ahmed, Arslan, Shukaib, Salhotra, Amandeep, Mei, Matthew, Pourhassan, Hoda, Koller, Paul B., Amanam, Idoroenyi, Agrawal, Vaibhav, Curtin, Peter T., Spielberger, Ricardo, Pullarkat, Vinod A., Aldoss, Ibrahim, Stewart, F. Mark, Smith, Eileen P., Forman, Stephen J, Stein, Anthony S., Marcucci, Guido, Budde, L. Elizabeth

Volltext